(Q37857797)

24 August 2017

1 reference

title

What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? (English)

1 reference

24 August 2017

Serena Del Turco

4

0 references

Giuseppina Basta

object named as

Giuseppina Basta

1

0 references

Amalia Gastaldelli

object named as

Amalia Gastaldelli

5

0 references

author name string

Teresa Navarra

2

1 reference

24 August 2017

Paolo De Simone

3

1 reference

24 August 2017

Franco Filipponi

6

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

published in

Liver Transplantation

1 reference

24 August 2017

volume

17

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

633-640

1 reference

The biology of the receptor for advanced glycation end products and its ligands

24 August 2017

cites work

1 reference

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation

21 January 2018

1 reference

Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells

21 January 2018

1 reference

RAGE: a multi-ligand receptor unveiling novel insights in health and disease

21 January 2018

1 reference

Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease

21 January 2018

1 reference

Role of the receptor for advanced glycation end products in hepatic fibrosis

21 January 2018

1 reference

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

21 January 2018

1 reference

Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay

21 January 2018

1 reference

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

Tissue-specific expression patterns of the RAGE receptor and its soluble forms—a result of regulated alternative splicing?

21 January 2018

1 reference

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

21 January 2018

1 reference

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

21 January 2018

1 reference

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.

21 January 2018

1 reference

Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice

21 January 2018

1 reference

RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB

21 January 2018

1 reference

A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC

21 January 2018

1 reference

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation

21 January 2018

1 reference

Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A.

21 January 2018

1 reference

Stem cells and liver regeneration.

21 January 2018

1 reference

RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

21 January 2018

1 reference

Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins

21 January 2018

1 reference

Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells

21 January 2018

1 reference

Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury.

21 January 2018

1 reference

HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling

21 January 2018

1 reference

Oxidative stress-associated rise of hepatic protein glycation increases inflammatory liver injury in uncoupling protein-2 deficient mice

21 January 2018

1 reference

Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.

21 January 2018

1 reference

Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats

21 January 2018

1 reference

High-mobility group box 1 protein activates hepatic stellate cells in vitro

21 January 2018

1 reference

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis

21 January 2018

1 reference

What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese prepubertal children?

21 January 2018

1 reference

Quality assurance, efficiency indicators and cost-utility of the evaluation workup for liver transplantation.

21 January 2018

1 reference

Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation

21 January 2018

1 reference

Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction

21 January 2018

1 reference

Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation

21 January 2018

1 reference

Long-term outcomes of liver transplantation: diabetes mellitus

21 January 2018

1 reference

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease

21 January 2018

1 reference

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

21 January 2018

1 reference

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/LT.22306

1 reference

24 August 2017

1 reference